TY - JOUR
T1 - Erratum
T2 - Kaempferol attenuates myocardial ischemic injury via inhibition of MAPK signaling pathway in experimental model of myocardial ischemia-reperfusion injury (Oxidative Medicine and Cellular Longevity (2016) 2016 (7580731) DOI: 10.1155/2016/7580731)
AU - Suchal, Kapil
AU - Malik, Salma
AU - Gamad, Nanda
AU - Malhotra, Rajiv Kumar
AU - Goyal, Sameer N.
AU - Chaudhary, Uma
AU - Bhatia, Jagriti
AU - Ojha, Shreesh
AU - Arya, Dharamvir Singh
N1 - Publisher Copyright:
Copyright © 2020 Kapil Suchal et al.
PY - 2020
Y1 - 2020
N2 - In the article titled "Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury"[1], it was identified that the beta-actin panels in Figures 4(a), 4(b), and 4(c) were identical. With the agreement of the editor, a revised version of Figure 4 is being provided with the data from a repeat of the experiment. The authors apologize for this error in the original publication.
AB - In the article titled "Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury"[1], it was identified that the beta-actin panels in Figures 4(a), 4(b), and 4(c) were identical. With the agreement of the editor, a revised version of Figure 4 is being provided with the data from a repeat of the experiment. The authors apologize for this error in the original publication.
UR - http://www.scopus.com/inward/record.url?scp=85087888669&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087888669&partnerID=8YFLogxK
U2 - 10.1155/2020/4530278
DO - 10.1155/2020/4530278
M3 - Comment/debate
C2 - 32655768
AN - SCOPUS:85087888669
SN - 1942-0900
VL - 2020
JO - Oxidative Medicine and Cellular Longevity
JF - Oxidative Medicine and Cellular Longevity
M1 - 4530278
ER -